1. Home
  2. MDGL vs VFS Comparison

MDGL vs VFS Comparison

Compare MDGL & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Madrigal Pharmaceuticals Inc.

MDGL

Madrigal Pharmaceuticals Inc.

HOLD

Current Price

$600.02

Market Cap

12.5B

Sector

Health Care

ML Signal

HOLD

Logo VinFast Auto Ltd.

VFS

VinFast Auto Ltd.

HOLD

Current Price

$3.39

Market Cap

7.9B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDGL
VFS
Founded
2011
2017
Country
United States
Vietnam
Employees
N/A
17823
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
12.5B
7.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MDGL
VFS
Price
$600.02
$3.39
Analyst Decision
Strong Buy
Buy
Analyst Count
14
4
Target Price
$580.77
$5.83
AVG Volume (30 Days)
277.7K
369.2K
Earning Date
11-04-2025
11-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$740,640,000.00
$2,554,394,588.00
Revenue This Year
$435.63
N/A
Revenue Next Year
$52.56
$43.19
P/E Ratio
N/A
N/A
Revenue Growth
864.21
81.20
52 Week Low
$265.00
$2.56
52 Week High
$615.00
$4.65

Technical Indicators

Market Signals
Indicator
MDGL
VFS
Relative Strength Index (RSI) 64.74 50.64
Support Level $535.33 $3.34
Resistance Level $615.00 $3.51
Average True Range (ATR) 19.64 0.12
MACD 0.57 0.01
Stochastic Oscillator 81.93 36.11

Price Performance

Historical Comparison
MDGL
VFS

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

Share on Social Networks: